According to Hong Kong Economic Daily, on the 20th, Hong Kong’s Office of the Key Enterprises (OASES) announced the list of the sixth batch of key enterprises, including U.S. pharmaceutical leader Pfizer, mainland pharmaceutical leader Hengrui Pharmaceuticals, chip design company Hygon Information, digital asset custody institution Cobo Fintech HK Limited, and stablecoin payment fintech company RedotPay, among others.



At the signing ceremony, Hong Kong Financial Secretary Paul Chan Mo-po said that the companies’ backgrounds are diverse. There are now 124 key enterprises, which are expected to bring 730 billion in investment and create 25,000 new jobs. He said that 75% will set up regional or international headquarters in Hong Kong, 90% will establish research centers, and many companies are also interested in moving to the Northern Metropolis.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin